Michaël Desjardins

Also affiliated with Harvard University, Centre Hospitalier de l’Université de Montréal

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “SARS-CoV-2 viral load is associated with increased disease severity and mortality”.

SARS-CoV-2 viral load is associated with increased disease severity and mortality

Nature Communications(2020)10.1038/s41467-020-19057-5

N/A

1.0DataRank · unranked

981 citations

James Regan, Kendyll Coxen, Heather Corry, Colline Wong, Alexandra Rosenthal +95 more

Risk of COVID-19 after natural infection or vaccination

EBioMedicine(2023)10.1016/j.ebiom.2023.104799

N/A

0.396DataRank · unranked

13 citations

Matthew B. Laurens, Ying Huang, Chenchen Yu, Thomas Martin, Carina A. Rodriguez +94 more

Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigens

Med(2021)10.1016/j.medj.2021.08.004

N/A

0DataRank · unranked

54 citations

Xavier Culleré, Matthew L. Settles, Xinge Ji, Michael W. Kattan, Michaël Desjardins +8 more

Protective heterologous T cell immunity in COVID-19 induced by MMR and Tdap vaccine antigens

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.03.441323

N/A

0DataRank · unranked

4 citations

Xavier Culleré, Matthew L. Settles, Xinge Ji, Michael W. Kattan, Michaël Desjardins +8 more

Anti-nucleocapsid antibodies following SARS-CoV-2 infection in the blinded phase of the mRNA-1273 Covid-19 vaccine efficacy clinical trial

medRxiv(2022)10.1101/2022.04.18.22271936

N/A

0DataRank · unranked

14 citations

Holly Janes, Olive D. Buhule, Honghong Zhou, Bethany Girard, Kristen Marks +8 more

Safety and immunogenicity of PanChol, a single-dose live-attenuated oral cholera vaccine: results from a phase 1a, double-blind, randomized, placebo-controlled trial

medRxiv(2025)10.1101/2025.09.12.25335655

N/A

0DataRank · unranked

0 citations

Stephen R. Walsh, Masataka Suzuki, Michaël Desjardins, Alisse Hannaford, Amy C Sherman +17 more